Market Cap (In AUD)
13.78 Million
Revenue (In AUD)
29.4 Million
Net Income (In AUD)
-32.05 Million
Avg. Volume
1.38 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.017-0.054
- PE
- -
- EPS
- -
- Beta Value
- 1.475
- ISIN
- AU0000022774
- CUSIP
- Q0267Q102
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Joshua Michael Fegan
- Employee Count
- -
- Website
- https://altheagroupholdings.com
- Ipo Date
- 2018-09-21
- Details
- Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Germany, Canada, and internationally. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.
More Stocks
-
TOPCFTopcon Corporation
TOPCF
-
NSHRF
-
5102Guan Chong Berhad
5102
-
688101
-
7148
-
603856
-
1556
-
COV